top
Search terms
Results 1 - 10 of 50 - ordered by :
Pages: 1 2 3 4 5 ... 5
Escardio

MASS II trial Paulo CURY REZENDE (Sao Paulo, BR) 14:00 P3365 Effect of the completeness revascularization in the survival of patients with stable multivessel coronary artery disease: 10-year ...

Poster session 4: Stable coronary disease

Date : 29/08/2011 Item size : 240012 bytes
Ehjcvp

Optimal handling of the healthy In the preventive section, the HOPE-3 (Heart Outcomes Prevention Evaluation 3) trial stole the limelight, first and foremost by strengthening faith in statinsthis time ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Manan Pareek, Deepak L. Bhatt

Date : 01/07/2016 Item size : 164372 bytes
Ehjcardiovascrec

Abstract Alteration of endothelial cell functions, including reduced endothelial nitric oxide (NO) availability, increased endothelial cell apoptosis, adhesion molecule/chemokine expression and ...

Cardiovascular Research, TOPICAL REVIEWS: SPOTLIGHT ON HDL BIOLOGY: NEW INSIGHTS IN METABOLISM, FUNCTION, AND TRANSLATION, Adelheid Kratzer, Hector Giral, Ulf Landmesser

Date : 01/08/2014 Item size : 745311 bytes
Ehjournal

In most countries aspirin was available as an over-the-counter remedy well before its widespread use in cardiovascular disease, which probably contributed to its widespread acceptability. [...]many ...

European Heart Journal, CURRENT OPINION, S. Ben Freedman, Bernard J. Gersh, Gregory Y. H. Lip

Date : 14/03/2015
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 08/03/2017 Item size : 424498 bytes
Ehjournal

Cardiovascular risk profile, levels of the complement factor C5a, and other non-specific inflammatory parameters [high sensitivity C-reactive protein, serum amyloid A (SAA), and fibrinogen] were ...

European Heart Journal, Speidl, Walter S., Exner, Markus, Amighi, Jasmin, Kastl, Stefan P., Zorn, Gerlinde, Maurer, Gerald, Wagner, Oswald, Huber, Kurt, Minar, Erich, Wojta, Johann, Schillinger, ...

Date : 01/11/2005
Ehjournal

[...]in these patients we investigated the impact of myeloperoxidase (MPOx) and C-reactive protein on the incidence of myocardial infarction and stroke. KaplanMeier curves for the four groups of ...

European Heart Journal, Brevetti, Gregorio, Schiano, Vittorio, Laurenzano, Eugenio, Giugliano, Giuseppe, Petretta, Mario, Scopacasa, Francesco, Chiariello, Massimo

Date : 01/01/2008
Ehjournal

Patients receiving statin therapy ( \(n=269\) , 52%) had a lower level of inflammation (hs-CRP \(p{<}0.001\) , SAA \(p=0.001\) , fibrinogen \(p=0.007\) , albumin \(p{<}0.001\) , neutrophils ...

European Heart Journal, Schillinger, Martin, Exner, Markus, Mlekusch, Wolfgang, Amighi, Jasmin, Sabeti, Schila, Muellner, Marcus, Rumpold, Helmut, Wagner, Oswald, Minar, Erich

Date : 01/05/2004
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 09/03/2017
Ehjournal

Cardiovascular risk profile, levels of the complement factor C5a, and other non-specific inflammatory parameters [high sensitivity C-reactive protein, serum amyloid A (SAA), and fibrinogen] were ...

European Heart Journal, Speidl, Walter S., Exner, Markus, Amighi, Jasmin, Kastl, Stefan P., Zorn, Gerlinde, Maurer, Gerald, Wagner, Oswald, Huber, Kurt, Minar, Erich, Wojta, Johann, Schillinger, ...

Date : 01/11/2005 Item size : 164144 bytes